Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture

Area of Science:

• Cardiology
• Cellular Biology
• Anesthesiology

Background:

• Acute reperfusion injury exacerbates myocardial damage after ischemia via cardiomyocyte hypercontracture.
• Halothane has demonstrated protective effects on ischemic-reperfused myocardium in previous studies.
• Understanding halothane's cellular mechanism against reoxygenation-induced hypercontracture is crucial.

Purpose of the Study:

• To investigate the cellular mechanism by which halothane protects against reoxygenation-induced hypercontracture in cardiomyocytes.
• To analyze the role of intracellular calcium (Ca2+) handling in halothane's protective effects.

Main Methods:

• Isolated adult rat cardiomyocytes were subjected to simulated ischemia-reperfusion.
• Intracellular Ca2+ and intracellular pH (pHi) were measured using fura 2 and BCECF, respectively.
• Hypercontracture was assessed microscopically in the presence or absence of halothane.

Main Results:

• Reoxygenation induced significant intracellular Ca2+ oscillations and hypercontracture in control cardiomyocytes.
• Halothane administration during reoxygenation markedly reduced Ca2+ oscillations and prevented hypercontracture.
• Halothane did not affect pHi recovery, and similar effects were observed with ryanodine or cyclopiazonic acid.

Conclusions:

• Halothane protects cardiomyocytes from reoxygenation-induced hypercontracture.
• This protection is mediated by the prevention of intracellular Ca2+ oscillations during early reoxygenation.
• The findings highlight a novel cellular mechanism for halothane's cardioprotective effects.